Pharmacological inhibition of MDM4 alleviates pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease of unknown etiology with no cure. A better understanding of the disease processes and identification of druggable targets will benefit the development of effective therapies for IPF. We previously reported that MDM4 promoted...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Qianru, Yang, Zhenhua, Xiang, Zhengkai, Zuo, He, Zhou, Zijing, Dong, Xiaochuan, Zhang, Ludan, Song, Wenhui, Wang, Yi, Hu, Qinghua, Zhou, Yong, Qu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240813/
https://www.ncbi.nlm.nih.gov/pubmed/37284444
http://dx.doi.org/10.7150/thno.81993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240813/
https://www.ncbi.nlm.nih.gov/pubmed/37284444
http://dx.doi.org/10.7150/thno.81993

Ejemplares similares